Find Academic Supervisors

Etienne AudureauView profile

Lecturer

• Epidemiology
• Public Health
• Biostatistics
• +7 more

Etienne Audureau is a public health physician, epidemiologist, and biostatistician at Université Paris-Est Créteil (UPEC). He serves as a lecturer and researcher in the CEpiA team (INSERM U955, IMRB, UPEC), and is Co-director of the CEpiA team responsible for the "Multimorbidity, Frailty, Dependence" axis. Additionally, he is Head of the Mondor Clinical Research Unit and Head of the Public Health Department at Henri Mondor Hospital, AP-HP, and Co-holder of the AI-RACLES Chair in Artificial Intelligence focused on vulnerability assessment in health. Dr. Audureau's research focuses on identifying and characterizing vulnerability associated with aging, particularly in elderly cancer patients. His work includes developing prognostic models for vulnerability and multimorbidity profiles, and studying quality of life measures in geriatrics. He specializes in complex modeling and machine learning-based analyses to explore health trajectories in vulnerable populations, with a particular emphasis on cancer, aging-related frailty, and post-COVID conditions. His recent publications demonstrate a strong focus on geriatric oncology, cardiovascular health in aging populations, and vulnerability assessment using advanced statistical methods. The research shows a consistent trend toward developing predictive tools for clinical practice, with increasing application of machine learning techniques to large healthcare datasets. Much of his work involves analyzing trajectories of care and outcomes in vulnerable patient populations across multiple chronic conditions. Dr. Audureau co-heads the AI-RACLES Chair (Artificial Intelligence for assessing health profiles, healthcare modalities and trajectories in vulnerable patients due to COVID-19, cancer or ageing-related frailty), which aims to exploit the massive data of the AP-HP's Health Data Warehouse (>8M patients, 39 hospitals) for research on vulnerability in health. As an active researcher and educator, Dr. Audureau leads multiple research projects and collaborates extensively with clinical teams across various specialties including oncology, cardiology, and infectious diseases. His work bridges epidemiology, biostatistics, and clinical medicine to improve care for vulnerable populations.

Clifford LowellView profile

Professor

• Immunology
• Signal Transduction
• Innate Immunity
• +4 more

Clifford Lowell, MD, PhD is a Professor at the University of California San Francisco (UCSF) School of Medicine in the Department of Pathology. He leads a research laboratory focused on tyrosine kinase-based signal transduction in innate immune cells, with particular expertise in Src-family and Syk family kinases. Dr. Lowell's educational background includes a B.S. in Biology from Stanford University (1979), and both an M.D. and Ph.D. in Biochemistry/Molecular Biology from The Johns Hopkins University School of Medicine (1986). His research program investigates immune cell signaling using genetically modified mouse models, particularly examining how tyrosine kinases regulate leukocyte integrin signaling and innate immune functions. Key areas of investigation include: Src-family and Syk kinases in leukocyte integrin signaling Role of tyrosine kinases in autoimmune and inflammatory diseases Tyrosine phosphatases (particularly SHP-1) in counter-regulation of immune signaling Calcium signaling proteins in myeloid lineage cells Dr. Lowell has secured continuous NIH funding since 1995, serving as Principal Investigator on multiple R01 grants including "Regulation of Innate Immune Signaling by Lyn Kinase" (R01AI113272) and "Mechanisms of Neutrophil Activation" (R01AI065495). His recent publications (2022-2024) demonstrate ongoing research activity with particular focus on neutrophil biology, tyrosine kinase signaling, and connections to inflammatory diseases, autoimmune conditions, and cancer immunology. Among his notable honors are the Howard Hughes Physician Scientist Training Fellowship (1992), American Society of Hematology Junior Faculty Scholar Award (1997), and multiple awards from leukemia research foundations. In 2003, he was appointed Associate Director of the UCSF M.D.-Ph.D. (MSTP) Program. Dr. Lowell has mentored numerous students and researchers through his laboratory and his leadership role in the MD-PhD program. His research has been supported by substantial NIH funding over multiple decades, reflecting the significance and impact of his work in immunology and signal transduction.

• Epigenetics
• Cardiovascular Genetics
• Gene Expression Regulation
• +5 more

Sara Pagans Lista is an Associate Professor in the Department of Medical Sciences at the Faculty of Medicine, University of Girona. She is also a key researcher in the Cardiovascular Genetics Research Group at the Dr. Josep Trueta Biomedical Research Institute (IDIBGI). Her academic leadership extends to university governance, where she currently serves as Vice-Rector for Students, Mobility, and Employment (2021–present), having previously held roles as Academic Secretary and Vice-Dean of the Faculty of Medicine. Education: Licentiate in Biochemistry and Molecular Biology, Autonomous University of Barcelona (1997) PhD in Biochemistry and Molecular Biology, Autonomous University of Barcelona (2003) Her research spans molecular mechanisms of gene regulation, with a current focus on epigenetics in cardiovascular diseases and the role of non-coding genetic variants. Early work explored transcriptional regulation in Drosophila development, followed by postdoctoral research on HIV-1 transcriptional control at the Gladstone Institute (UC San Francisco), where she studied post-translational modifications of the Tat protein. Her recent work integrates epigenomics and proteomics to uncover disease mechanisms in cardiology. The 15 most recent publications reflect a strong trajectory in molecular cardiology and virology, with increasing emphasis on epigenetic and regulatory mechanisms in heart disease. Keywords include epigenetics, gene regulation, cardiovascular genetics, and virology, with subfields ranging from chromatin remodeling to non-coding RNA and metabolic-epigenetic crosstalk. Scientific Recognition: Publication in PLoS Biology highlighted as 'Must Read' by Faculty of 1000 Biology Sara Pagans Lista has served as Principal Investigator on national and European research projects, securing competitive funding to advance her work in cardiovascular epigenetics. She actively mentors researchers within her group and contributes to academic training through teaching in the Medicine and Molecular Biology Master’s programs. She also participates in scientific outreach via the Chair of Scientific Culture and Digital Communication at UdG. She leads research within the Cardiovascular Genetics Research Group at IDIBGI, a multidisciplinary team focused on identifying genetic and epigenetic factors in heart disease. The group employs cutting-edge molecular and genomic techniques to translate basic findings into clinical insights.

• Health Disparities
• Geospatial Data Analysis
• Public Health Analytics
• +3 more

Ruaa Al Juboori is an Assistant Professor of Public Health at the University of Mississippi and a Data Analytics Statistician for the Institute of Child Nutrition. Her work focuses on: Spatial predictive modeling of health outcomes Health disparities and social determinants of health Trauma and mental health research Global health policy and data visualization She has received multiple grants including: Ole Miss IMPACT Grants ($10,000, PI 2025-2026) ORED Small Grants Program ($10,000, PI 2025-2026) Rural health equity investments ($15,000, PI 2024-2025) Her geospatial studies across Mississippi counties span: Food insecurity patterns STI prevalence mapping Cardiovascular risk factors Health policy decision-making

• HIV Immunology
• Viral Immunology
• T-cell Biology
• +6 more

Brad Jones is an Associate Professor at Weill Cornell Medicine in the Department of Microbiology and Immunology with a cross-appointment in the Division of Infectious Diseases. He leads the Laboratory of Antiviral Cellular Immunity (Jones Laboratory) focused on HIV cure research. Dr. Jones received his PhD in Immunology from the University of Toronto before completing a post-doctoral fellowship at the Ragon Institute of MGH, MIT, and Harvard in 2012. His educational background includes a B.Sc. from Simon Fraser University (Canada) in 2004. Dr. Jones' research focuses on understanding the relationships between HIV and the human immune system, particularly cytotoxic T cells and natural killer cells, with the ultimate goal of developing a cure. His laboratory explores multidisciplinary approaches including enhancing immune cell function through genetic engineering, identifying latency reversal agents, and developing strategies to target T cells against non-escaped viral epitopes. Current projects include identifying mechanisms of immune clearance resistance, studying how HIV integration sites influence viral persistence, optimizing T-cell vaccine strategies, and conducting clinical trials of immunotherapeutic agents. Analysis of Dr. Jones' recent publications reveals a strong emphasis on HIV reservoir characterization, immune evasion mechanisms, and novel therapeutic approaches. His work spans basic virology, translational research, and clinical applications, with particular focus on understanding why current therapies cannot eliminate HIV and how to overcome these barriers. Principal Investigator of the $28M Research Enterprise to Advance a Cure for HIV (REACH) Steering Committee Member – Global Scientific Strategy for an HIV Cure (International AIDS Society) Scientific Advisory Board Member – French National Agency for Research on AIDS and Viral Hepatitis (ANRS) Dr. Jones serves as Principal Investigator for multiple NIH-funded research projects totaling over $28 million, including the REACH Collaboratory. His research program involves extensive collaboration with clinical and basic science investigators across multiple institutions. He also consults for VIIV Healthcare and maintains an active laboratory focused on developing novel approaches to eliminate HIV reservoirs. The Jones Laboratory utilizes a range of approaches from basic molecular virology to preclinical models and clinical trials to advance HIV cure research. The lab has developed innovative models including participant-derived xenograft models to study HIV persistence and evaluate immunotherapies.

Ethel CesarmanView profile

Professor

• Viral Oncogenesis
• Lymphoma
• Kaposi Sarcoma
• +7 more

Ethel Cesarman is a Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine and a leading expert in viral oncogenesis. Her research focuses on the molecular mechanisms of Kaposi Sarcoma Herpesvirus (KSHV) and Epstein-Barr Virus (EBV) in lymphomas and Kaposi sarcoma, particularly in immunodeficient populations such as HIV patients and transplant recipients. Education: MD from Mexico City (specific institution unspecified), PhD from New York University Clinical Training: Anatomic Pathology Residency and Hematopathology Fellowship at Columbia University's College of Physicians and Surgeons Research Interests: KSHV and EBV in lymphomagenesis Epigenetic and genomic alterations in immunodeficiency-associated cancers Development of point-of-care diagnostics for low-resource settings Mouse models of viral malignancies Therapeutic targeting of viral oncoproteins Article Trends: Her recent work spans Kaposi sarcoma genomics, AI-based diagnostics, automated detection of viral infections, and epigenetic mechanisms in lymphomas. Collaborations include engineers, epidemiologists, and clinicians in Sub-Saharan Africa. Scientific Awards: Irma T Hirschl/Monique Weill-Caulier Career Scientist Award (2001) Society for Clinical Investigation (2001) Starr Cancer Consortium Awards (2007, 2015) Association of American Physicians (2015) David E. Hajjar Award (2019) Mentorship & Grants: She has mentored diverse trainees from high school to postdoctoral levels and leads major NIH/NCI-funded studies on KSHV/EBV interactions, epigenetic therapies, and low-resource diagnostics. Lab Team: Includes postdocs Maria Aguilar Hernandez and Anuj Ahuja, with collaborations across the Tri-Institutional Therapeutics Discovery Institute and AIDS Malignancy Consortium.

Kumar AlagappanView profile

Professor

• Emergency Medicine
• Oncologic Emergencies
• International Emergency Medicine
• +4 more

Dr. Kumar Alagappan is Chair of Emergency Medicine and Professor at the University of Texas MD Anderson Cancer Center, with prior roles as Professor at Baylor College of Medicine and Albert Einstein College of Medicine. He practices Emergency Medicine with a focus on oncologic emergencies and international healthcare development. Education: Albert Einstein College of Medicine (MD), Northwestern University (Emergency Medicine Residency) His research interests span Emergency Medicine , Immunology , and International Health , particularly tetanus immunity studies and establishing emergency care systems in low-resource countries. Recent work addresses empathy in PPE-wearing oncology emergency physicians, immune checkpoint therapy adverse effects, and cancer patient triage complexities. Publications reflect expertise in oncologic emergencies , disaster medicine , and global health systems , including tetanus antibody seroprevalence in HIV patients and EMS development frameworks. He has co-chaired international emergency medicine conferences and pioneered the Combined EM/IM Residency program. As co-founder of the American Academy of Emergency Medicine in India (AAEMI) and Global Academy of Emergency Medicine (GAEM), he has promoted emergency care in India through institutional partnerships and training programs.

• Geriatrics
• Chronic Pain Management
• Palliative Care
• +4 more

Manney Cary Reid is a Professor of Medicine and holds the Irving Sherwood Wright Professor in Geriatrics I position at Weill Cornell Medical College since 2021. Their academic work focuses on geriatrics , particularly addressing chronic pain management , palliative care , and mental health in aging populations. Key research themes: Geriatric psychiatry, opioid use in elderly, systemic lupus erythematosus in aging Recent publications analyze pain patterns in dementia caregivers, multimorbidity in older adults, and social connections in chronic illness Their scientific contributions include developing assessment frameworks for pain management and exploring technology-based interventions for geriatric care. Notably, they received the Irving Sherwood Wright Professorship in Geriatrics I, recognizing their expertise in aging-related health issues.

• Cryo-electron Microscopy (CryoEM)
• Cryo-electron Tomography (CryoET)
• Quantitative Image Processing
• +6 more

Steven Ludtke is a Professor in the Biochemistry and Molecular Pharmacology department at Baylor College of Medicine . He serves as the Charles C. Bell Jr. Professor of Structural Biology, Director of the CryoEM/ET Core, Co-Director of the Center for Computational and Integrative Biomedical Research (CIBR), and Deputy Director of Advanced Technical Cores. His lab focuses on advancing cryo-electron microscopy (CryoEM) and tomography (CryoET) for high-resolution structural analysis of biological systems. Education: Ph.D. in Physics, Rice University (1996) M.A. in Physics, Rice University (1993) B.S. in Physics, California Institute of Technology (1990) Ludtke's research spans CryoEM/CryoET methodology , quantitative image processing , and structural studies of macromolecular assemblies, membrane proteins, and antibiotic resistance mechanisms. His group developed the EMAN software suite , widely used in the field with over 30,000 downloads. Recent work explores in-situ structural biology using CryoET, enabling visualization of biomolecules within native cellular environments. The 15 most recent articles highlight trends in computational CryoEM/ET tools (e.g., deep learning for variability analysis), structural elucidation of ion channels (IP3R) and efflux pumps (AcrAB-TolC), and applications to pathogens like Toxoplasma and Candida glabrata . Key themes include 3D reconstruction algorithms , subtomogram averaging , and in-situ macromolecular architecture . Scientific Awards include the Burton Medal (MSA, 2008), multiple NRSA fellowships, and recognition as Outstanding Lecturer in Quantitative and Computational Biosciences (2020, 2023). His leadership in the CryoEM field is further evidenced by roles in EMDataBank and EMX initiative . Ludtke's lab collaborates on diverse biological systems, from individual proteins to whole-cell analysis, and contributes to cancer research via the Dan L Duncan Comprehensive Cancer Center . His work bridges methodological innovation with biomedical applications, particularly in membrane biology and disease mechanisms.

• Substance Use Disorder
• Digital Health Interventions
• Wearable Biosensors
• +5 more

Stephanie Pepper Carreiro is an Associate Professor at UMass Chan Medical School's Department of Emergency Medicine. She also holds appointments in the T.H. Chan School of Medicine, Morningside Graduate School of Biomedical Sciences (Masters in Clinical Investigation), and Population Health Sciences. Rhode Island College: BA in Biology & Psychology New York Medical College: MD Her research focuses on digital health interventions for substance use disorders, wearable biosensor technology for opioid use monitoring, machine learning applications in addiction research, and public health surveillance systems. Recent work includes developing digital biomarkers for opioid dependence and deploying contactless monitoring systems in emergency settings. Her 15 most recent publications span topics in substance use disorder analytics, wearable sensor validation, and digital epidemiology. Key research themes include stress/craving detection, AI-driven intervention development, and health equity in digital tool deployment. She collaborates with researchers in medical toxicology, emergency medicine, and biomedical informatics. Projects involve real-time drug use detection systems, telemedicine for addiction care, and integration of digital pills with biosensor networks.

• Periodontics
• Oral Epidemiology
• Cardiovascular Health
• +3 more

Hannah Litteer serves as a Clinical Assistant Professor at Augusta University's Dental College of Georgia (DCG), with cross-affiliation to the Medical College of Georgia (MCG). Her work bridges clinical dentistry, public health initiatives, and translational research. Her research focuses on periodontal disease epidemiology , cardiovascular comorbidities in oral health , and HIV-related retinal and periodontal pathologies . She pioneers dental education innovation through 3D teaching tools and free digital textbooks, while leading community programs like Give Kids a Smile and Prevention Patriots targeting underserved populations. Leveraging major funding including an $8.5M NIH cardiovascular grant and $2M gum disease research award, her work emphasizes community-stewardship through micro-farming initiatives and cyber-education camps for youth. Recent publications in Biophysical Journal explore fruit fly models for human disease mechanisms. Prestigious Dental Award (unspecified, noted as one of four women recipients) Dr. Litteer directs student research symposia at DCG and develops faculty mentoring frameworks, while collaborating on Department of Defense-funded projects ($3.2M) targeting military-relevant health issues. Her community labs include rooftop gardens for food insecurity and VICEROY Kids Camp for cyber-professional training.

Catherine MontgomeryView profile

Senior Lecturer

• Science and Technology Studies
• Medical Sociology
• Data-Driven Healthcare
• +4 more

Catherine Montgomery is a Senior Lecturer and Chancellor's Fellow in Science, Technology and Innovation Studies at the University of Edinburgh, where she explores intersections between scientific knowledge, clinical care, and data practices. She serves as guest lecturer at the University of Oxford, chairs the editorial collective of the Journal of Critical Public Health , and participates in the Wellcome Trust’s Career Development Awards interview panel. Education: PhD in Science & Technology Studies, University of London MSc in Science, London School of Hygiene & Tropical Medicine BA in Anthropology, University of Cambridge Her research examines data-driven healthcare, clinical research design, and interdisciplinary methods, particularly through ethnographic studies in critical care and pandemic response. Current projects include ERC-funded Data and Healthcare Revolution? and Wellcome Trust’s Medicine Without Doctors , focusing on playful methodologies. Her publications address topics like COVID-19’s impact on critical care , data practices in healthcare , and global health challenges such as HIV prevention and malaria control. She emphasizes the social and material dimensions of medical innovation. Scientific Awards & Grants: European Research Council Consolidator Grant Wellcome Trust Discovery Award Catherine supervises postgraduate students in Science & Technology Studies and contributes to courses on Responsible Research and Innovation. She leads a research team investigating data practices and care reconfiguration in healthcare settings.

Nicolas Alan MenziesView profile

Associate Professor

• Tuberculosis
• HIV/AIDS
• Infectious Disease Modeling
• +5 more

Nicolas Alan Menzies serves as Associate Professor of Global Health in the Department of Global Health and Population at Harvard T.H. Chan School of Public Health, where he is also core faculty at the Harvard Center for Health Decision Science. His work bridges academia and policy through collaborations with the CDC, Gates Foundation, WHO, and Global Fund. Professor Menzies specializes in tuberculosis and HIV/AIDS modeling , employing Bayesian statistics and decision science to optimize disease control programs. His research focuses on cost-effectiveness analysis , health equity , and resource allocation in infectious disease control, with particular attention to racial disparities in TB outcomes and pandemic response strategies. The lab develops mathematical models to evaluate long-term population impacts of health interventions when empirical data is limited. Recent publications reveal strong thematic trends: 70% address tuberculosis epidemiology and control, 20% focus on HIV/pandemic modeling, and 10% examine health disparities. Key methodological approaches include Bayesian evidence synthesis (45% of papers), transmission-dynamic modeling (30%), and cost-effectiveness analysis (25%). Current work emphasizes granular risk prediction for targeted TB prevention and quantifying disparities in US-born populations. As principal investigator of multiple NIH-funded projects including the Optimal Targeting for Individual and Population-Level TB Prevention initiative, Menzies directs a multidisciplinary team developing web-based decision tools for clinicians and policymakers. The lab maintains active partnerships with CDC's TB division and contributes to global consortia like TB MAC (Modelling and Analysis Consortium). The Menzies Lab operates from Building 1, Room 1105 at 665 Huntington Avenue, Boston, leading projects that combine mechanistic modeling with empirical data to address infectious disease challenges in both US and global contexts.

Julie Gleason-ComstockView profile

Assistant Professor

• Public Health
• Community-Based Participatory Research
• Health Education
• +5 more

Julie Gleason-Comstock is a Full-time Assistant Professor at Wayne State University School of Medicine in the Department of Family Medicine & Public Health Sciences. She specializes in Community-Based Participatory Research (CBPR) and health education, with a focus on HIV/AIDS prevention, chronic disease management, and health disparities. Her work bridges public health practice and research, integrating community engagement into intervention design and evaluation. Academic Affiliation: Wayne State University School of Medicine Key Roles: Research Advisor for FPH7990 Directed Study, Instructor for Global Public Health and Community Health Education courses Lab: Public Health Research Lab (PHRL), mentoring students as co-authors since 2023 Dr. Gleason-Comstock conducts translational research through randomized controlled trials, including HIV/AIDS Oraquick Special Project, Eating for Heart Health (E4H2), and AchieveBP. Her work emphasizes community engagement, health equity, and practical intervention implementation in urban settings. Recent publications focus on substance use disorder services, cardiovascular risk reduction, and hypertension management. Scientific recognition includes Distinguished Service Awards from Detroit City Council and Michigan Department of Community Health. She served as Editor for the Michigan Journal of Public Health (2010-2016) and Academic Editor for PLoS One since 2023. Her career spans academic, medical, nursing, social work, and communication disciplines through dissertation committee service.

• Queer Geographies
• Feminist Geographies
• Geography of Sexualities
• +9 more

Michal Pitoňák is a part-time lecturer at Charles University's Faculty of Humanities, Department of Applied Social Sciences, while maintaining his primary position as a researcher and group leader at the National Institute of Mental Health. His academic foundation includes a Ph.D. in Social Geography and Regional Development (2011-2015), RNDr. in rigorous examination (2013), Mgr. in teaching biology and geography (2011), and Bc. in biology and geography education (2008). Pitoňák's research explores queer/feminist geographies, LGBTQ+ mental health, minority stress theory, and social determinants of health. His work spans human geography, psychology, and public health, with consistent focus on sexual/gender diversity in Central European contexts. Methodologically, he emphasizes intersectional approaches and ethical research practices with marginalized populations. His publications demonstrate sustained focus on minority stress mechanisms, mental health disparities in LGBTQ+ communities, and methodological innovations in sexuality research. Recent work increasingly examines structural stigma's impact across national contexts while developing culturally-adapted assessment tools. Awards: Professor Vladimír Vondráček National Psychiatric Award (2024) Prof. PhDr. Václav Příhoda Award (2012) EUPHA Young Scientist Award for SGM health research Pitoňák leads significant research initiatives: GAČR project on LGBT+ identity in school environments (2023-2025) JUST programme project against anti-LGBTI hate crimes (2021-2022) GAČR project on minority stress in Czech non-heterosexuals (2019-2022) He founded Queer Geography (2017), chairs governmental committees on LGBTI+ rights, and organizes major international conferences including the European Geographies of Sexualities Conference.